These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11448045)

  • 1. Extrusion-Spheronization of blends of carbopol 934 and microcrystalline cellulose.
    Gómez-Carracedo A; Alvarez-Lorenzo C; Gómez-Amoza JL; Martínez-Pacheco R; Souto C; Concheiro A
    Drug Dev Ind Pharm; 2001 May; 27(5):381-91. PubMed ID: 11448045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of к-carrageenan, chitosan and Carbopol 974P in extruded and spheronized pellets that are devoid of MCC.
    Valle BL; Omwancha WS; Neau SH; Wigent RJ
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1903-16. PubMed ID: 27100683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of drying on microstructure and drug release profiles from tablets of MCC-lactose-Carbopol and MCC-dicalcium phosphate-Carbopol pellets.
    Gómez-Carracedo A; Souto C; Marti Nez-Pacheco R; Concheiro A; Gómez-Amoza JL
    Eur J Pharm Biopharm; 2008 Jun; 69(2):675-85. PubMed ID: 18248805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
    Ibrahim MA
    Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of extrusion aids for successful production of Kollidon
    Loka NC; Saripella KK; Pinto CA; Neau SH
    Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of storage condition on properties of MCC II-based pellets with theophylline-monohydrate.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2014 Oct; 88(2):483-91. PubMed ID: 24950003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization.
    Heng PW; Koo OM
    Pharm Res; 2001 Apr; 18(4):480-7. PubMed ID: 11451035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torque rheological parameters to predict pellet quality in extrusion-spheronization.
    Soh JL; Liew CV; Heng PW
    Int J Pharm; 2006 Jun; 315(1-2):99-109. PubMed ID: 16574352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P; Steffens KJ; Kleinebudde P
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to developing fast release pellets via wet extrusion-spheronization.
    Xia Y; Shi CY; Fang JG; Wang WQ
    Pharm Dev Technol; 2018 Jun; 23(5):432-441. PubMed ID: 27882815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization.
    Koo OM; Heng PW
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1383-7. PubMed ID: 11724226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of starch-based pellets via extrusion/spheronisation.
    Dukić A; Mens R; Adriaensens P; Foreman P; Gelan J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2007 Apr; 66(1):83-94. PubMed ID: 17045467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D; Kleinebudde P
    Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of Carbopol 974P and Carbopol 971P pellets by extrusion-spheronization: optimization of the processing parameters and water content.
    Mezreb N; Charrueau C; Boy P; Allain P; Chaumeil JC
    Drug Dev Ind Pharm; 2004 May; 30(5):481-90. PubMed ID: 15244083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
    Fechner PM; Wartewig S; Füting M; Heilmann A; Neubert RH; Kleinebudde P
    AAPS PharmSci; 2003 Nov; 5(4):E31. PubMed ID: 15198519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization.
    Boutell S; Newton JM; Bloor JR; Hayes G
    Int J Pharm; 2002 May; 238(1-2):61-76. PubMed ID: 11996811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.